1. Home
  2. NBIX vs SUN Comparison

NBIX vs SUN Comparison

Compare NBIX & SUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$131.62

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Sunoco LP

SUN

Sunoco LP

HOLD

Current Price

$68.34

Market Cap

12.2B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
SUN
Founded
1992
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Integrated oil Companies
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
12.2B
IPO Year
1996
2012

Fundamental Metrics

Financial Performance
Metric
NBIX
SUN
Price
$131.62
$68.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
22
6
Target Price
$180.91
$68.33
AVG Volume (30 Days)
1.1M
301.4K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
5.45%
EPS Growth
41.95
N/A
EPS
4.67
N/A
Revenue
$161,626,000.00
$25,201,000,000.00
Revenue This Year
$24.73
$63.67
Revenue Next Year
$13.14
$0.84
P/E Ratio
$28.21
$26.93
Revenue Growth
977.51
11.05
52 Week Low
$108.47
$47.98
52 Week High
$160.18
$69.53

Technical Indicators

Market Signals
Indicator
NBIX
SUN
Relative Strength Index (RSI) 53.32 61.39
Support Level $124.62 $62.43
Resistance Level $135.30 N/A
Average True Range (ATR) 3.41 1.41
MACD 0.17 0.39
Stochastic Oscillator 70.73 80.57

Price Performance

Historical Comparison
NBIX
SUN

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About SUN Sunoco LP

Sunoco LP is engaged in the distribution of motor fuels to independent dealers, distributors, and other commercial customers as well as the distribution of motor fuels to end-use customers at retail sites operated by commission agents. It is a growth-oriented master limited partnership (MLP) that operates as a wholesale and retail fuel distributor in the United States. The firm operates through the Fuel Distribution; Pipeline Systems; Refinery and Terminals segments. It generates the majority of its revenue from the Fuel Distribution segment. It distributes motor fuel to convenience stores, dealers, and commercial customers in various states.

Share on Social Networks: